Greater Manchester-based start-up named Augmented Healthcare has launched an AI powered clinical care dashboard helping to identify early warning signs of serious illness, following £19,000 in innovation grant funding and support from GM Business Growth Hub’s Innovation Service.
Founded by Jonti Hudson, a practicing GP and computer engineer, the company’s Consultation Dashboard (CoDa) platform reportedly listens passively to patient-clinician conversations, picking up any “red flags” that may signal potential serious illness, and raising them for clinical consideration.
The £19,000 innovation grant is said to have helped fund a five-month product development project focused on inviting external specialists to work on data generation, model tuning, clinical evaluation, and a full system audit. Augmented Healthcare now highlights its strengthened AI engine and clear route to regulatory validation.
“This project has allowed us to build a stronger and safer AI engine ready for clinical settings,” said Hudson. “The funding accelerated technical development, but the strategic guidance has been equally important. The support helped us understand where our product fits in Greater Manchester’s fast moving health innovation landscape.”
Yvonne Grady, GM Business Growth Hub’s head of innovation, added: “They’ve created an incredibly powerful, market‑first product that gives clinicians rapid, reliable insight into early signs of serious illness supporting faster decisions, better outcomes, and ultimately safer patient care. With clear regulatory pathways, validated infrastructure and a stronger strategic direction, Augmented Healthcare is now well prepared to launch its pioneering clinical consultation tool for the AI age.”
Wider trend: AI innovation
HTN was joined for a deep dive into AI strategy, implementation, adoption, and opportunities by Neill Crump, group associate director of innovation & partnerships at The Dudley Group and Sandwell and West Birmingham, and Pip Hodgson, group digital transformation specialist at University Hospitals of Leicester and Northamptonshire. Our panel discussed their organisation’s approaches to AI and AI strategy, best practices in AI strategy development, Ambient Voice Technology and successful implementation, and the opportunities likely to be ahead with the next wave of AI.
Liverpool-based Spotlight Pathology has secured £1.4 million in seed funding to support the development of its AI-powered blood cancer diagnostics software. The funding round was co-led by the UK Innovation and Science Seed Fund (UKI2S) and Liverpool City Region Seed Fund. Funding will be used toward product development, regulation, and clinical adoption for the company’s AI software capable of analysing digital pathology images to support the earlier identification of blood cancers.
A study funded by the National Institutes of Health has developed an AI tool offering clinical decision support to clinicians by predicting patients at risk of intimate partner violence (IPV) from data collected during medical visits. Led by researchers from Harvard Medical School, the study trained a machine learning model using several years of hospital data from around 850 female patients affected by IPV, along with 5,200 control patients matched on age and demographics.
